Ser95

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Phosphorylation Site Page: > Ser95 - TGM1 (human)

Site Information
RRPVsRGsGVNAAGD SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 468935

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 )
Disease tissue studied:	breast cancer ( 2 ) , breast cancer, surrounding tissue ( 1 ) , breast cancer, triple negative ( 2 )
Relevant cell line - cell type - tissue:	breast ( 1 , 2 )

References
1	Mertins P, et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55-62 27251275 Curated Info
2	Mertins P, et al. (2014) Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics 13, 1690-704 24719451 Curated Info

Developed with grants from

and literature mining with Linguamatics

PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.